Medication info

Combiplex Injection

Prescription medicationSolutionIntravenous injection
Ingredient · strength
L-Isoleucine›2.8gL-Leucine›6.25gL-Lysine Acetate›6.2gL-Methionine›1.75gL-Phenylalanine›4.68gL-Threonine›3.25gL-Tryptophan›0.65gL-Valine›2.25gL-Alanine›3.1gL-Arginine›3.95gL-Histidine›3gL-Proline›1.65gL-Serine›1.1gGlycine›5.35gL-Aspartic Acid›1.9gL-Cysteine›0.5gL-Glutamic Acid›3.25gL-Tyrosine›0.18gMonobasic Potassium Phosphate›2.04gSodium Acetate Hydrate›5.019gGlucose›250gSodium Chloride›401mgPotassium Chloride›1864mgMagnesium Chloride Hydrate›635mgCalcium Chloride Hydrate›414mg
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
A pale yellow, transparent liquid filled in a transparent plastic container with one or more partitions inside.
Packaging
1000 mL (Solution A: 500 mL, Solution B: 500 mL)/Box
Approval status
Active

MFDS item code 200308581 · Notified 2003.10.24 · Insurance code 644903890

Summary

Main use
Correction of deficiencies in intravenous nutrition (amino acids and calories), fluids, and electrolytes
Who receives it
Adults · Children
Adult administration
Immediately before administration, open the partition and mix the contents of solutions A and B before use. ○ Adults: The maximum dose is 1–1.5 g/kg/day of total amino acids. ○ Infusion rate: Do not exceed 1.0 mL/kg per hour (equivalent to 0.2 5g/kg glucose and 0.05 g/kg amino acids). Administration by infusion through a central venous catheter over 12–24 hours is recommended; as a rule, this medicine should be administered through a central venous catheter. In older adults and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.
Child administration
In children, adjust the dose and infusion rate as appropriate.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Correction of deficiencies in intravenous nutrition (amino acids and calories), fluids, and electrolytes

View approved original text

This medication provides necessary water, electrolytes, amino acids, and calories to patients when oral or gastrointestinal nutrition is not possible. It is particularly used in cases requiring intravenous nutrition, helping to improve the nutritional status of the patient and assist in recovery. It plays an important therapeutic role in maintaining normal metabolism and supplementing physical strength.

How it is given

Adult administration

Immediately before administration, open the partition and mix the contents of solutions A and B before use. ○ Adults: The maximum dose is 1–1.5 g/kg/day of total amino acids. ○ Infusion rate: Do not exceed 1.0 mL/kg per hour (equivalent to 0.2 5g/kg glucose and 0.05 g/kg amino acids). Administration by infusion through a central venous catheter over 12–24 hours is recommended; as a rule, this medicine should be administered through a central venous catheter. In older adults and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Child administration

In children, adjust the dose and infusion rate as appropriate.

Precautions

This medication should only be used according to a doctor's instructions. When used with calcium-containing drugs via intravenous route, care should be taken to avoid mixing with ceftriaxone, and the same infusion device should not be used simultaneously. This medication should not be administered to patients with allergies to egg or soy protein, or certain diseases such as hypernatremia, hyperchloremia, or hyperkalemia. Special caution is necessary for patients with heart disease, renal or liver dysfunction, severe dehydration, or severe blood coagulation disorders when using this medication. Patients sensitive to sulfite components, particularly those with asthma, should be cautious as allergic reactions or asthma attacks may occur. During administration, blood glucose, electrolyte levels, and liver and kidney function should be monitored regularly, and any abnormal symptoms should be reported to healthcare providers immediately. High blood sugar, acidosis, edema, liver function abnormalities, allergic reactions, gastrointestinal symptoms, etc., may occur, so symptoms should be carefully observed. During pregnancy or breastfeeding, the safety of this medication is not fully established, so it should be administered cautiously based on a doctor’s judgment. In children, especially infants under the age of 2, the safety is not established, and it is advisable not to use it. Elderly patients may have decreased body function, so the infusion rate should be slow, and the dosage should be adjusted. In the case of overdose, treatments like blood dialysis may be needed, and careful attention should be paid to dosage and infusion rate adjustments. This medication should be administered slowly via central vein and should not be infused through peripheral veins. Maintain sterile conditions during administration, and do not use if the solution is discolored or the packaging is damaged. Store unopened at room temperature, avoiding freezing. During the administration of this medication, the patient’s condition should be closely monitored, and necessary tests should be conducted to ensure safety.

Side effects

  • edema
  • cerebral edema
  • pulmonary edema
  • peripheral edema
  • water intoxication
  • hyperglycemia
  • hyperosmotic diuresis
  • thirst
  • liver dysfunction
  • hyperkalemia
Show 31 more
  • elevated BUN
  • urticaria
  • rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • hypertension
  • hypophosphatemia
  • alkalosis
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • chills
  • fever
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urethral spasm
  • peripheral vasodilation
  • hypertension
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering and should preferably be kept at a cool room temperature. Avoid direct sunlight and extreme temperatures to help maintain the efficacy of the medication.

Appearance and packaging

Appearance

A pale yellow, transparent liquid filled in a transparent plastic container with one or more partitions inside.

Package unit

1000 mL (Solution A: 500 mL, Solution B: 500 mL)/Box

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.